Keyphrases
Disease States
100%
Clinical Decision-making
100%
Prostate Cancer
100%
Piflufolastat
100%
Treatment Plan
100%
Prostate-specific Membrane Antigen Positron Emission Tomography
100%
F-18
100%
Retrospective Review
100%
Biochemical Recurrence
60%
Initial Staging
60%
Prostate-specific Antigen
60%
Positron Emission Tomography
60%
Clinical Care
40%
Metastatic Disease
40%
Metastatic Lesions
40%
18F-DCFPyL
40%
Descriptive Statistics
20%
Restaging
20%
U.S. Food
20%
Local Recurrence
20%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
20%
Patient Management
20%
High-grade Prostate Cancer
20%
Survival Outcomes
20%
Extraprostatic
20%
Consecutive Patients
20%
Treatment Information
20%
Medicine and Dentistry
Prostate Specific Membrane Antigen
100%
Disease
100%
Prostate Cancer
100%
Positron Emission Tomography
100%
Clinical Decision Making
100%
Biochemical Recurrence
42%
Metastatic Carcinoma
28%
Fluorine-18
28%
Recurrent Disease
14%
Prostate Specific Antigen
14%
Neuroscience
Prostate Specific Membrane Antigen
100%
Clinical Decision Making
100%
Positron Emission Tomography
100%
Fluorine-18
28%
Prostate
14%
Prostate Specific Antigen
14%